Skip to main content

Table 3 Association between NAC regimens/cycles and adverse events (neutropenia and lymphopenia)

From: Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma

 

Neutropenia

Lymphopenia

Grade 3

Grade 4

Grade 3

Grade 4

NAC regimen, n (%)

 FP

5 (11%)

1 (2%)

3 (7%)

0

 DCF

11 (35%)

16 (52%)

7 (23%)

0

NAC cycles, n (%)

 1

1 (4%)

4 (16%)

5 (20%)

0

 2

15 (27%)

13 (24%)

5 (9%)

0